Innoveix Recalls Lyophilized Human Chorionic Gonadotropin Due to Sterility Concerns
Innoveix Pharmaceuticals is recalling 413 vials of Lyophilized Human Chorionic Gonadotropin 5,000 USP Units due to a lack of sterility assurance.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of sterility assurance in an injectable drug, which poses a significant risk of infection and potential hospitalization.
Plain-English summary
Innoveix Pharmaceuticals Inc is recalling 413 vials of Lyophilized Human Chorionic Gonadotropin 5,000 USP Units for injection. The recall is being conducted because of a lack of sterility assurance in the product.
The affected product is compounded by Innoveix in Addison, TX, and was distributed nationwide within the United States. The recall covers specific lots identified as INX 910 with an expiration date of 2/7/20 and INX 915 with an expiration date of 3/12/20.
Consumers and healthcare providers should stop using the recalled product and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- Lyophilized Human Chorionic Gonadotropin 5,000 USP Units For injection, Rx Only, Compounded by: Innoveix Addison, TX 75001 800-370-1910
- Manufacturer
- Innoveix Pharmaceuticals Inc
- Category
- Drug — Injectable
- Affected units
- 413
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: INX 910 Exp. 2/7/20
- INX 915 Exp. 3/12/20
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 4 recalled by Innoveix Pharmaceuticals Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · Innoveix Pharmaceuticals Inc
See all →- SevereCompounded Lyophilized AOD-9604 Injection Recalled for Sterility Risk
FDA (Drugs) · 2021-07-28
- SevereCompounded Semorelin/Ipamorelin Injection Recalled for Sterility Assurance
FDA (Drugs) · 2021-07-28
- SevereInnoveix Recalls Lyophilized Human Chorionic Gonadotropin Due to Sterility Concerns
FDA (Drugs) · 2019-11-06
- SevereInnoveix Recalls Lyophilized Chorionic Gonadotropin Due to Sterility Concerns
FDA (Drugs) · 2019-11-06
- SevereInnoveix Recalls Lyophilized Sermorelin Injection Due to Sterility Concerns
FDA (Drugs) · 2019-11-06
Same hazard · infection
See all →- HighArrowhead DE LLC Recalls Arrow-LOK Implants Due to Sterility Assurance Concerns
FDA (Devices) · 2026-08-26
- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- HighSurgipro Sutures Recalled for Potential Sterile Barrier Perforation
FDA (Devices) · 2026-08-19
- HighV-Loc 180 Absorbable Wound Closure Device Recalled for Packaging Defects
FDA (Devices) · 2026-08-19
- HighV-Loc 90 Absorbable Wound Closure Devices Recalled for Packaging Defects
FDA (Devices) · 2026-08-19